Cerebellar hemangioblastomas
Between 1950 and 1976, 24 patients with cerebellar hemangioblastomas received postoperative radiation therapy. In retrospect, the low‐dose radiotherapy that was practiced in the 1950s and early 1960s has been associated wiht inferior survival rates. Since 1963 and with increased awareness of the eff...
Gespeichert in:
| Veröffentlicht in: | Cancer 1982-02, Vol.49 (3), p.553-555 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 555 |
|---|---|
| container_issue | 3 |
| container_start_page | 553 |
| container_title | Cancer |
| container_volume | 49 |
| creator | Sung, Duk Il Chang, Chu H. Harisiadis, Leon |
| description | Between 1950 and 1976, 24 patients with cerebellar hemangioblastomas received postoperative radiation therapy. In retrospect, the low‐dose radiotherapy that was practiced in the 1950s and early 1960s has been associated wiht inferior survival rates. Since 1963 and with increased awareness of the effects of radiotherapy, patients receiving high‐dose irradiation postoperatively have generally survived longer. Postoperative radiotherapy is used whenever the neoplasm has not been totally excised. This more likely to occur with solid hemangioblastoma and neoplasms arising in the brain stem. In addition, radiotherapy should be used when the tumor recurs after total excision. The recommended dose is in the range of 4500–5000 rads in 4 1/2–5 weeks. |
| doi_str_mv | 10.1002/1097-0142(19820201)49:3<553::AID-CNCR2820490326>3.0.CO;2-A |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73996073</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73996073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3836-8b6a5ac932ea062b96af61b798e9e9eabde5c27d9e8072a6f33a57e714a776d03</originalsourceid><addsrcrecordid>eNqVkE9LAzEQxYMotVa_gYIn0cPWSWY32VQR1vVfoVgQBfEyZLepVna7ddMi_famtBb0IEgOQ3gz7838GLvk0OYA4pSDVgHwUBxzHQsQwE9C3cHzKMJOJ-leBel9-iC8EmpAIS-wDe20fyaCZIM118ObrAkAcRCF-LzNdpx7918lImywhuJaoxJNtp_a2ma2KEx9-GZLM34dVVlh3LQqjdtlW0NTOLu3qi32dHP9mN4Fvf5tN016QY4xyiDOpIlMrlFYA1JkWpqh5JnSsdX-mWxgo1yogbaxzzdyiGgiZRUPjVJyANhiR0vfSV19zKybUjly-WKpsa1mjhRqLUGhb3xZNuZ15VxthzSpR6Wp58SBFuhocT0trqdvdBRqQvLoiDw6-onOK0BpnwQl3vxgtcUsK-1gbb1i5XW71D9HhZ3_K_nP4F8KfgGpEYoO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73996073</pqid></control><display><type>article</type><title>Cerebellar hemangioblastomas</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Sung, Duk Il ; Chang, Chu H. ; Harisiadis, Leon</creator><creatorcontrib>Sung, Duk Il ; Chang, Chu H. ; Harisiadis, Leon</creatorcontrib><description>Between 1950 and 1976, 24 patients with cerebellar hemangioblastomas received postoperative radiation therapy. In retrospect, the low‐dose radiotherapy that was practiced in the 1950s and early 1960s has been associated wiht inferior survival rates. Since 1963 and with increased awareness of the effects of radiotherapy, patients receiving high‐dose irradiation postoperatively have generally survived longer. Postoperative radiotherapy is used whenever the neoplasm has not been totally excised. This more likely to occur with solid hemangioblastoma and neoplasms arising in the brain stem. In addition, radiotherapy should be used when the tumor recurs after total excision. The recommended dose is in the range of 4500–5000 rads in 4 1/2–5 weeks.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19820201)49:3<553::AID-CNCR2820490326>3.0.CO;2-A</identifier><identifier>PMID: 7199372</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adolescent ; Adult ; Aged ; Cerebellar Neoplasms - radiotherapy ; Cerebellar Neoplasms - surgery ; Female ; Hemangiosarcoma - radiotherapy ; Hemangiosarcoma - surgery ; Humans ; Male ; Middle Aged ; Prognosis ; Radiotherapy Dosage ; Retrospective Studies</subject><ispartof>Cancer, 1982-02, Vol.49 (3), p.553-555</ispartof><rights>Copyright © 1982 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3836-8b6a5ac932ea062b96af61b798e9e9eabde5c27d9e8072a6f33a57e714a776d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7199372$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sung, Duk Il</creatorcontrib><creatorcontrib>Chang, Chu H.</creatorcontrib><creatorcontrib>Harisiadis, Leon</creatorcontrib><title>Cerebellar hemangioblastomas</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Between 1950 and 1976, 24 patients with cerebellar hemangioblastomas received postoperative radiation therapy. In retrospect, the low‐dose radiotherapy that was practiced in the 1950s and early 1960s has been associated wiht inferior survival rates. Since 1963 and with increased awareness of the effects of radiotherapy, patients receiving high‐dose irradiation postoperatively have generally survived longer. Postoperative radiotherapy is used whenever the neoplasm has not been totally excised. This more likely to occur with solid hemangioblastoma and neoplasms arising in the brain stem. In addition, radiotherapy should be used when the tumor recurs after total excision. The recommended dose is in the range of 4500–5000 rads in 4 1/2–5 weeks.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Cerebellar Neoplasms - radiotherapy</subject><subject>Cerebellar Neoplasms - surgery</subject><subject>Female</subject><subject>Hemangiosarcoma - radiotherapy</subject><subject>Hemangiosarcoma - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Radiotherapy Dosage</subject><subject>Retrospective Studies</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE9LAzEQxYMotVa_gYIn0cPWSWY32VQR1vVfoVgQBfEyZLepVna7ddMi_famtBb0IEgOQ3gz7838GLvk0OYA4pSDVgHwUBxzHQsQwE9C3cHzKMJOJ-leBel9-iC8EmpAIS-wDe20fyaCZIM118ObrAkAcRCF-LzNdpx7918lImywhuJaoxJNtp_a2ma2KEx9-GZLM34dVVlh3LQqjdtlW0NTOLu3qi32dHP9mN4Fvf5tN016QY4xyiDOpIlMrlFYA1JkWpqh5JnSsdX-mWxgo1yogbaxzzdyiGgiZRUPjVJyANhiR0vfSV19zKybUjly-WKpsa1mjhRqLUGhb3xZNuZ15VxthzSpR6Wp58SBFuhocT0trqdvdBRqQvLoiDw6-onOK0BpnwQl3vxgtcUsK-1gbb1i5XW71D9HhZ3_K_nP4F8KfgGpEYoO</recordid><startdate>19820201</startdate><enddate>19820201</enddate><creator>Sung, Duk Il</creator><creator>Chang, Chu H.</creator><creator>Harisiadis, Leon</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19820201</creationdate><title>Cerebellar hemangioblastomas</title><author>Sung, Duk Il ; Chang, Chu H. ; Harisiadis, Leon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3836-8b6a5ac932ea062b96af61b798e9e9eabde5c27d9e8072a6f33a57e714a776d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Cerebellar Neoplasms - radiotherapy</topic><topic>Cerebellar Neoplasms - surgery</topic><topic>Female</topic><topic>Hemangiosarcoma - radiotherapy</topic><topic>Hemangiosarcoma - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Radiotherapy Dosage</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sung, Duk Il</creatorcontrib><creatorcontrib>Chang, Chu H.</creatorcontrib><creatorcontrib>Harisiadis, Leon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sung, Duk Il</au><au>Chang, Chu H.</au><au>Harisiadis, Leon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebellar hemangioblastomas</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1982-02-01</date><risdate>1982</risdate><volume>49</volume><issue>3</issue><spage>553</spage><epage>555</epage><pages>553-555</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Between 1950 and 1976, 24 patients with cerebellar hemangioblastomas received postoperative radiation therapy. In retrospect, the low‐dose radiotherapy that was practiced in the 1950s and early 1960s has been associated wiht inferior survival rates. Since 1963 and with increased awareness of the effects of radiotherapy, patients receiving high‐dose irradiation postoperatively have generally survived longer. Postoperative radiotherapy is used whenever the neoplasm has not been totally excised. This more likely to occur with solid hemangioblastoma and neoplasms arising in the brain stem. In addition, radiotherapy should be used when the tumor recurs after total excision. The recommended dose is in the range of 4500–5000 rads in 4 1/2–5 weeks.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>7199372</pmid><doi>10.1002/1097-0142(19820201)49:3<553::AID-CNCR2820490326>3.0.CO;2-A</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 1982-02, Vol.49 (3), p.553-555 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_73996073 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adolescent Adult Aged Cerebellar Neoplasms - radiotherapy Cerebellar Neoplasms - surgery Female Hemangiosarcoma - radiotherapy Hemangiosarcoma - surgery Humans Male Middle Aged Prognosis Radiotherapy Dosage Retrospective Studies |
| title | Cerebellar hemangioblastomas |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T10%3A24%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebellar%20hemangioblastomas&rft.jtitle=Cancer&rft.au=Sung,%20Duk%20Il&rft.date=1982-02-01&rft.volume=49&rft.issue=3&rft.spage=553&rft.epage=555&rft.pages=553-555&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19820201)49:3%3C553::AID-CNCR2820490326%3E3.0.CO;2-A&rft_dat=%3Cproquest_cross%3E73996073%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73996073&rft_id=info:pmid/7199372&rfr_iscdi=true |